Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,428 | -147,958 | -10,982 | -2,455 | -34,066 |
| Depreciation Amortization | 287 | N/A | N/A | N/A | N/A |
| Other Working Capital | -2,482 | 1,043 | 302 | 256 | 110 |
| Other Operating Activity | 5,339 | 132,436 | 2,240 | -4,311 | 29,613 |
| Operating Cash Flow | $-18,284 | $-14,480 | $-8,439 | $-6,510 | $-4,343 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -375 | -148 | N/A | N/A | N/A |
| Investing Cash Flow | $-375 | $-148 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 817 | 71,317 | 6,028 | 7,833 | 11,684 |
| Common Stock Repurchased | N/A | -72 | -311 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | -48 | -906 |
| Financing Cash Flow | $817 | $71,245 | $5,718 | $7,785 | $10,778 |
| Beginning Cash Position | 61,747 | 5,129 | 7,851 | 6,577 | 142 |
| End Cash Position | 43,904 | 61,747 | 5,129 | 7,851 | 6,577 |
| Net Cash Flow | $-17,843 | $56,618 | $-2,722 | $1,275 | $6,435 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,284 | -14,480 | -8,439 | -6,510 | -4,343 |
| Capital Expenditure | -375 | -148 | N/A | N/A | N/A |
| Free Cash Flow | -18,659 | -14,628 | -8,439 | -6,510 | -4,343 |